(Q83757871)

English

Phase I study of atacicept in relapsed/refractory multiple myeloma (MM) and Waldenström's macroglobulinemia

scientific article published on 01 February 2011

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

21454215

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21454215%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 January 2020

title

Phase I study of atacicept in relapsed/refractory multiple myeloma (MM) and Waldenström's macroglobulinemia (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

21454215

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21454215%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 January 2020

main subject

Waldenström macroglobulinemia

1 reference

Jean-François Rossi

1

1 reference

stated in

Europe PubMed Central

PubMed ID

21454215

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21454215%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 January 2020

publication date

1 February 2011

1 reference

stated in

Europe PubMed Central

PubMed ID

21454215

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21454215%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 January 2020

published in

Clinical Lymphoma, Myeloma & Leukemia

1 reference

stated in

Europe PubMed Central

PubMed ID

21454215

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21454215%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 January 2020

volume

11

1 reference

stated in

Europe PubMed Central

PubMed ID

21454215

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21454215%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 January 2020

issue

1

1 reference

stated in

Europe PubMed Central

PubMed ID

21454215

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21454215%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 January 2020

page(s)

136-138

1 reference

stated in

Europe PubMed Central

PubMed ID

21454215

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21454215%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 January 2020

Identifiers

DOI

10.3816/CLML.2011.N.031

1 reference

stated in

Europe PubMed Central

PubMed ID

21454215

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21454215%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

Europe PubMed Central

PubMed ID

21454215

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21454215%20AND%20SRC:MED&resulttype=core&format=json

(Q83757871)

Phase I study of atacicept in relapsed/refractory multiple myeloma (MM) and Waldenström's macroglobulinemia

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)